BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210225T080000
DTEND;TZID=America/New_York:20210225T090000
DTSTAMP:20260507T031119
CREATED:20210218T031112Z
LAST-MODIFIED:20210218T031112Z
UID:2045-1614240000-1614243600@www.mdtechcouncil.com
SUMMARY:Biotech Connector Speaker Series: Liquid Biopsies
DESCRIPTION:On February 25\, the Biotech Connector series will highlight exciting research on liquid biopsies with two talks by local investigators: Chris Karlovich\, Ph.D.\, associate director of the Molecular Characterization Laboratory at the Frederick National Laboratory for Cancer Research and Yves Konigshofer\, Ph.D.\, director of technology development at LGC Clinical Diagnostics Division. \nLiquid biopsies are highly sensitive blood tests that can detect fragments of tumor DNA\, also known as circulating tumor DNA (ctDNA)\, in the blood—providing critical information about the tumor without an invasive tumor biopsy. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/biotech-connector-speaker-series-liquid-biopsies/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210225T120000
DTEND;TZID=America/New_York:20210225T130000
DTSTAMP:20260507T031119
CREATED:20210219T183149Z
LAST-MODIFIED:20210219T183149Z
UID:2057-1614254400-1614258000@www.mdtechcouncil.com
SUMMARY:Healthworx Challenge: To advance health equity by engaging communities in improving and managing healthcare.
DESCRIPTION:Meet the challenge! Be part of the solution!\nGet involved and find out how you or your company can get connected with Healthworx to improve healthcare equity. \nRegister to attend the Healthworx challenge statement release webinar. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/healthworx-challenge-to-advance-health-equity-by-engaging-communities-in-improving-and-managing-healthcare/
END:VEVENT
END:VCALENDAR